Respiratory Virus Vaccines Market

Respiratory Virus Vaccines Market Analysis by Inactivated/Killed, Live-attenuated, and Recombinant for Influenza, Measles, Mumps, & Rubella, and Coronavirus Disease (COVID-19) from 2023 to 2033

By Fact.MR Healthcare Desk Lead analyst: S.N. Jha Published : Updated : 1 min read Fact-checked under the Fact.MR editorial process

Inside The Report

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Risks & Trends Assessment

4. Market Background and Associated Industry Indicators

5. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033

6. Global Market - Pricing Analysis

7. Global Market Demand (in US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
  • 8.1. Inactivated/Killed Vaccines
  • 8.2. Live-attenuated Vaccines
  • 8.3. Recombinant Vaccines
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration
  • 9.1. Intramuscular
  • 9.2. Intranasal
  • 9.3. Subcutaneous
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication
  • 10.1. Influenza
  • 10.2. Measles, Mumps & Rubella
  • 10.3. Coronavirus Disease (COVID-19)
11. Global Market Value (US$ Mn) Forecast, by Age Group
  • 11.1. Pediatric
  • 11.2. Adults

12. Global Market Attractiveness Analysis, by Age Group

13. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
  • 13.1. Physician’s Office
  • 13.2. Hospitals
  • 13.3. Clinics
  • 13.4. Pharmacies/Stores
14. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
  • 14.1. North America
  • 14.2. Latin America
  • 14.3. Europe
  • 14.4. Asia Pacific
  • 14.5. Middle East & Africa

15. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

16. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

17. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033

18. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033

19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033

20. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033

21. Market Structure Analysis

22. Competition Analysis
  • 22.1. CSL Limited
  • 22.2. Sanofi
  • 22.3. AstraZeneca
  • 22.4. Merck & Co., Inc.
  • 22.5. GlaxoSmithKline plc
  • 22.6. Serum Institute of India Pvt. Ltd.
  • 22.7. Bharat Biotech
  • 22.8. Sinovac Biotech Ltd.

23. Assumptions and Acronyms Used

24. Research Methodology

List of Tables

Table 01: Pipeline Analysis (1/4)

Table 02: Pipeline Analysis (2/4)

Table 03: Pipeline Analysis (3/4)

Table 04: Pipeline Analysis (4/4)

Table 05: Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (1/3)

Table 06: Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (2/3)

Table 07: Key Industry Events (Mergers, Acquisitions, Collaborations, Approvals, etc.) (3/3)

Table 08: Global Market Value (US$ Mn) Forecast, by Type, 2023 to 2033

Table 09: Global Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033

Table 10: Global Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033

Table 11: Global Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033

Table 12: Global Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 13: Global Market Value (US$ Mn) Forecast, by Region, 2023 to 2033

Table 14: North America Market Value (US$ Mn) Forecast, by Country, 2023 to 2033

Table 15: North America Market Value (US$ Mn) Forecast, by Type, 2023 to 2033

Table 16: North America Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033

Table 17: North America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033

Table 18: North America Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033

Table 19: North America Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 20: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 21: Europe Market Value (US$ Mn) Forecast, by Type, 2023 to 2033

Table 22: Europe Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033

Table 23: Europe Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033

Table 24: Europe Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033

Table 25: Europe Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 26: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 27: Asia Pacific Market Value (US$ Mn) Forecast, by Type, 2023 to 2033

Table 28: Asia Pacific Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033

Table 29: Asia Pacific Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033

Table 30: Asia Pacific Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033

Table 31: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 32: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 33: Latin America Market Value (US$ Mn) Forecast, by Type, 2023 to 2033

Table 34: Latin America Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033

Table 35: Latin America Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033

Table 36: Latin America Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033

Table 37: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 38: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 39: Middle East & Africa Market Value (US$ Mn) Forecast, by Type, 2023 to 2033

Table 40: Middle East & Africa Market Value (US$ Mn) Forecast, by Route of Administration, 2023 to 2033

Table 41: Middle East & Africa Market Value (US$ Mn) Forecast, by Indication, 2023 to 2033

Table 42: Middle East & Africa Market Value (US$ Mn) Forecast, by Age Group, 2023 to 2033

Table 43: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

List of Figures

Figure 01: Global Market Value (US$ Mn) Forecast, 2023 to 2033

Figure 02: Global Market Value Share Analysis, by Type, 2018 and 2022

Figure 03: Global Market Attractiveness Analysis, by Type, 2018 to 2022

Figure 04: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Inactivated/Killed Vaccines, 2023 to 2033

Figure 05: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Live-attenuated Vaccines, 2023 to 2033

Figure 06: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Recombinant vaccines, 2023 to 2033

Figure 07: Global Market Value Share Analysis, by Route of Administration, 2018 and 2022

Figure 08: Global Market Attractiveness Analysis, by Route of Administration, 2018 to 2022

Figure 09: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Intramuscular, 2023 to 2033

Figure 10: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Intranasal, 2023 to 2033

Figure 11: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Subcutaneous, 2023 to 2033

Figure 12: Global Market Value Share Analysis, by Indication, 2018 and 2022

Figure 13: Global Market Attractiveness Analysis, by Indication, 2018 to 2022

Figure 14: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Influenza, 2023 to 2033

Figure 15: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Measles, Mumps & Rubella, 2023 to 2033

Figure 16: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Coronavirus Disease (COVID-19), 2023 to 2033

Figure 17: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2023 to 2033

Figure 18: Global Market Value Share Analysis, by Age Group, 2018 and 2022

Figure 19: Global Market Attractiveness Analysis, by Age Group, 2018 to 2022

Figure 20: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Pediatric, 2023 to 2033

Figure 21: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Adult, 2023 to 2033

Figure 22: Global Market Value Share Analysis, by End-user, 2018 and 2022

Figure 23: Global Market Attractiveness Analysis, by End-user, 2018 to 2022

Figure 24: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Physician Offices, 2023 to 2033

Figure 25: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2023 to 2033

Figure 26: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Clinics, 2023 to 2033

Figure 27: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Pharmacy/Store, 2023 to 2033

Figure 28: Global Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2023 to 2033

Figure 29: Global Market Value Share Analysis, by Region, 2018 and 2022

Figure 30: Global Market Attractiveness Analysis, by Region, 2018 to 2022

Figure 31: North America Market Value (US$ Mn) Forecast, 2023 to 2033

Figure 32: North America Market Value Share Analysis, by Country, 2018 and 2022

Figure 33: North America Market Attractiveness Analysis, by Country, 2018 to 2022

Figure 34: North America Market Value Share Analysis, by Type, 2018 and 2022

Figure 35: North America Market Attractiveness Analysis, by Type, 2018 to 2022

Figure 36: North America Market Value Share Analysis, by Route of Administration, 2018 and 2022

Figure 37: North America Market Attractiveness Analysis, by Route of Administration, 2018 to 2022

Figure 38: North America Market Value Share Analysis, by Indication, 2018 and 2022

Figure 39: North America Market Attractiveness Analysis, by Indication, 2018 to 2022

Figure 40: North America Market Value Share Analysis, by Age Group, 2018 and 2022

Figure 41: North America Market Attractiveness Analysis, by Age Group, 2018 to 2022

Figure 42: North America Market Value Share Analysis, by End-user, 2018 and 2022

Figure 43: North America Market Attractiveness Analysis, by End-user, 2018 to 2022

Figure 44: Europe Market Value (US$ Mn) Forecast, 2023 to 2033

Figure 45: Europe Market Value Share Analysis, by Country/Sub-region, 2018 and 2022

Figure 46: Europe Market Attractiveness Analysis, by Country, 2018 to 2022

Figure 47: Europe Market Value Share Analysis, by Type, 2018 and 2022

Figure 48: Europe Market Attractiveness Analysis, by Type, 2018 to 2022

Figure 49: Europe Market Value Share Analysis, by Route of Administration, 2018 and 2022

Figure 50: Europe Market Attractiveness Analysis, by Route of Administration, 2018 to 2022

Figure 51: Europe Market Value Share Analysis, by Indication, 2018 and 2022

Figure 52: Europe Market Attractiveness Analysis, by Indication, 2018 to 2022

Figure 53: Europe Market Value Share Analysis, by Age Group, 2018 and 2022

Figure 54: Europe Market Attractiveness Analysis, by Age Group, 2018 to 2022

Figure 55: Europe Market Value Share Analysis, by End-user, 2018 and 2022

Figure 56: Europe Market Attractiveness Analysis, by End-user, 2018 to 2022

Figure 57: Asia Pacific Market Value (US$ Mn) Forecast, 2023 to 2033

Figure 58: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2018 and 2022

Figure 59: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2018 to 2022

Figure 60: Asia Pacific Market Value Share Analysis, by Type, 2018 and 2022

Figure 61: Asia Pacific Market Attractiveness Analysis, by Type, 2018 to 2022

Figure 62: Asia Pacific Market Value Share Analysis, by Route of Administration, 2018 and 2022

Figure 63: Asia Pacific Market Attractiveness Analysis, by Route of Administration, 2018 to 2022

Figure 64: Asia Pacific Market Value Share Analysis, by Indication, 2018 and 2022

Figure 65: Asia Pacific Market Attractiveness Analysis, by Indication, 2018 to 2022

Figure 66: Asia Pacific Market Value Share Analysis, by Age Group, 2018 and 2022

Figure 67: Asia Pacific Market Attractiveness Analysis, by Age Group, 2018 to 2022

Figure 68: Asia Pacific Market Value Share Analysis, by End-user, 2018 and 2022

Figure 69: Asia Pacific Market Attractiveness Analysis, by End-user, 2018 to 2022

Figure 70: Latin America Market Value (US$ Mn) Forecast, 2023 to 2033

Figure 71: Latin America Market Value Share Analysis, by Country/Sub-region, 2018 and 2022

Figure 72: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2018 to 2022

Figure 73: Latin America Market Value Share Analysis, by Type, 2018 and 2022

Figure 74: Latin America Market Attractiveness Analysis, by Type, 2018 to 2022

Figure 75: Latin America Market Value Share Analysis, by Route of Administration, 2018 and 2022

Figure 76: Latin America Market Attractiveness Analysis, by Route of Administration, 2018 to 2022

Figure 77: Latin America Market Value Share Analysis, by Indication, 2018 and 2022

Figure 78: Latin America Market Attractiveness Analysis, by Indication, 2018 to 2022

Figure 79: Latin America Market Value Share Analysis, by Age Group, 2018 and 2022

Figure 80: Latin America Market Attractiveness Analysis, by Age Group, 2018 to 2022

Figure 81: Latin America Market Value Share Analysis, by End-user, 2018 and 2022

Figure 82: Latin America Market Attractiveness Analysis, by End-user, 2018 to 2022

Figure 83: Middle East & Africa Market Value (US$ Mn) Forecast, 2023 to 2033

Figure 84: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2018 and 2022

Figure 85: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2018 to 2022

Figure 86: Middle East & Africa Market Value Share Analysis, by Type, 2018 and 2022

Figure 87: Middle East & Africa Market Attractiveness Analysis, by Type, 2018 to 2022

Figure 88: Middle East & Africa Market Value Share Analysis, by Route of Administration, 2018 and 2022

Figure 89: Middle East & Africa Market Attractiveness Analysis, by Route of Administration, 2018 to 2022

Figure 90: Middle East & Africa Market Value Share Analysis, by Indication, 2018 and 2022

Figure 91: Middle East & Africa Market Attractiveness Analysis, by Indication, 2018 to 2022

Figure 92: Middle East & Africa Market Value Share Analysis, by Age Group, 2018 and 2022

Figure 93: Middle East & Africa Market Attractiveness Analysis, by Age Group, 2018 to 2022

Figure 94: Middle East & Africa Market Value Share Analysis, by End-user, 2018 and 2022

Figure 95: Middle East & Africa Market Attractiveness Analysis, by End-user, 2018 to 2022

Who worked on this report

Preview the report firsthand - request a free sample

Free Sample

Get the brochure for pricing and purchase details

Download PDF
Explore More

Related Reports

Respiratory Virus Vaccines Market

Request a Free Sample

Your personal details are safe with us. Privacy Policy